Full Text Journal Articles by
Author Jessica Coker

Advertisement

Find full text journal articles








Peripartum management for women with opioid dependence.

Jarna R Shah, Abigail Ramseyer, Jessica Coker,

<h4>Purpose of review</h4>Opioid use disorder (OUD) in pregnancy has more than quadrupled in prevalence over the past two decades and continues to increase steadily every year. With no defined standard of care for the management of pain during the peripartum period, variability in treatment plans potentially leaves room for interrupted ... Read more >>

Curr Opin Anaesthesiol (Current opinion in anaesthesiology)
[2021, 34(3):226-232]

Cited: 0 times

View full text PDF listing >>



Clearance of buprenorphine during pregnancy and neonatal outcomes.

Jessica L Coker, Shona L Ray-Griffith, Cody McLeod, Xiaotong Han, Michael Mancino, Gregory L Kearns, Zachary N Stowe,

Buprenorphine is emerging as the preferred pharmacologic treatment for opioid use disorder during pregnancy. We examined the relative plasma clearance of buprenorphine (BUP) across pregnancy. Pregnant women with opioid use disorder participating in a prospective, observational study from 2013 to 2016 on stress in pregnancy who were receiving BUP for ... Read more >>

Arch Womens Ment Health (Archives of women's mental health)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Advertisement

Continuous Fetal Monitoring During Electroconvulsive Therapy: A Prospective Observation Study.

Nader Rabie, Ronak Shah, Shona Ray-Griffith, Jessica L Coker, Everett F Magann, Zachary N Stowe,

<h4>Objective</h4>The use of electroconvulsive therapy in pregnancy has been limited by concerns about its effects on fetal well-being, despite limited evidence that suggests it is safe and effective. No studies have utilized continuous fetal heart rate monitoring during electroconvulsive therapy sessions. We aimed to describe the fetal heart rate patterns ... Read more >>

Int J Womens Health (International journal of women's health)
[2021, 13:1-7]

Cited: 0 times

View full text PDF listing >>



Buprenorphine Medication for Opioid Use Disorder: A Study of Factors Associated With Postpartum Treatment Retention.

Shona Ray-Griffith, Emily Tharp, Jessica L Coker, David Catlin, Bettina Knight, Zachary N Stowe,

<h4>Background and objectives</h4>The factors associated with medication for opioid use disorder (MOUD) treatment retention among pregnant women with opioid use disorder (OUD) are largely unknown. This study sought to characterize factors associated with postpartum treatment retention.<h4>Methods</h4>A retrospective chart review from 2014 to 2017 was conducted among women with OUD in ... Read more >>

Am J Addict (The American journal on addictions)
[2021, 30(1):43-48]

Cited: 0 times

View full text PDF listing >>



Drug screening during pregnancy: Urine dip cups measure up.

Emily B Kroska, Elizabeth W Meller, Rena Doyle, Jessica L Coker, Bettina T Knight, Shona L Ray-Griffith, Wendy N Nembhard, Zachary N Stowe,

<h4>Background</h4>Substance use during pregnancy is a major medical and public health concern. Determination of the most appropriate screening protocol remains a clinical conundrum. Interviews and/or laboratory drug screens may be costly, inaccurate, and are frequently inadequate to identify patterns of substance use for a given population or geographic area. We ... Read more >>

Drug Alcohol Depend (Drug and alcohol dependence)
[2019, 204:107461]

Cited: 0 times

View full text PDF listing >>



Magnetocardiographic identification of prolonged fetal corrected QT interval in women receiving treatment for opioid use disorder.

Elijah H Bolin, Diana Escalona-Vargas, Joshua A Daily, Eric R Siegel, Curtis L Lowery, Jessica Coker, Zachary N Stowe, Hari Eswaran,

<h4>Aim</h4>Pregnant women undergoing treatment for opioid use disorder (OUD) may be exposed to multiple QT prolonging agents. We used magnetocardiography to measure fetal QT intervals in mothers with OUD on buprenorphine therapy.<h4>Methods</h4>Fetal and maternal magnetocardiography was performed in pregnant women receiving buprenorphine-assisted treatment (Disorder group); these were matched by gestational ... Read more >>

J Obstet Gynaecol Res (The journal of obstetrics and gynaecology research)
[2019, 45(10):1989-1996]

Cited: 0 times

View full text PDF listing >>



Buprenorphine medication-assisted treatment during pregnancy: An exploratory factor analysis associated with adherence.

Jessica L Coker, David Catlin, Shona Ray-Griffith, Bettina Knight, Zachary N Stowe,

<h4>Background</h4>The treatment of pregnant women with opioid use disorder is challenging due to the myriad of physical, mental, and social complications. Factors influencing adherence to buprenorphine during pregnancy have not been identified.<h4>Materials and methods</h4>Pregnant women with opioid use disorder followed in a tertiary clinic were included in a retrospective chart ... Read more >>

Drug Alcohol Depend (Drug and alcohol dependence)
[2018, 192:146-149]

Cited: 3 times

View full text PDF listing >>



Fetal assessment in buprenorphine-maintained women using fetal magnetoencephalography: a pilot study.

Diana Escalona-Vargas, Jessica L Coker, Shona Ray-Griffith, Eric R Siegel, Curtis L Lowery, Zachary N Stowe, Hari Eswaran,

<h4>Background and aims</h4>In-utero exposure to opioids including buprenorphine (BUP) has been shown to affect fetal activity, specifically heart-rate variability (FHRV) and fetal movement (FM). Our objective was to extract simultaneous recordings of fetal cardiac and brain-related activity in BUP-maintained and non-opioid exposed pregnant women using a novel non-invasive biomagnetic technique.<h4>Design</h4>A ... Read more >>

Addiction (Addiction (Abingdon, England))
[2018, 113(10):1895-1904]

Cited: 0 times

View full text PDF listing >>



Rating scale item assessment of self-harm in postpartum women: a cross-sectional analysis.

Jessica L Coker, Shanti P Tripathi, Bettina T Knight, Page B Pennell, Everett F Magann, D Jeffrey Newport, Zachary N Stowe,

We examined the utility of screening instruments to identify risk factors for suicidal ideation (SI) in a population of women with neuropsychiatric illnesses at high risk for postpartum depression. Pregnant women with neuropsychiatric illness enrolled prior to 20 weeks of gestation. Follow-up visits at 4-8-week intervals through 13 weeks postpartum included assessment ... Read more >>

Arch Womens Ment Health (Archives of women's mental health)
[2017, 20(5):687-694]

Cited: 1 time

View full text PDF listing >>



Pregnant Women, Babies and Substance Use: Prevention of Neonatal Abstinence Syndrome.

Jessica L Coker, Alan Mease, Curtis Lowery,

J Ark Med Soc (The Journal of the Arkansas Medical Society)
[2017, 113(11):264-265]

Cited: 0 times

View full text PDF listing >>



Perinatal Substance Abuse: At the Clinical Crossroads of Policy and Practice.

Samuel J House, Jessica L Coker, Zachary N Stowe,

Am J Psychiatry (The American journal of psychiatry)
[2016, 173(11):1077-1080]

Cited: 1 time

View full text PDF listing >>



Pregnancy and Electroconvulsive Therapy: A Multidisciplinary Approach.

Shona L Ray-Griffith, Jessica L Coker, Nader Rabie, Lou Ann Eads, Kimberly J Golden, Zachary N Stowe,

<h4>Objective</h4>To scrutinize a series of pregnant women treated with electroconvulsive therapy (ECT) at a tertiary treatment center and combine these data with a literature review to refine the treatment guidelines for ECT during pregnancy.<h4>Methods</h4>A retrospective chart review of mentally ill pregnant patients treated with ECT since the establishment of a ... Read more >>

J ECT (The journal of ECT)
[2016, 32(2):104-112]

Cited: 8 times

View full text PDF listing >>





Advertisement

Disclaimer
1.124 s